Application of Wearable Technology in High-risk Surgical Patients in the Perioperative Period
Launched by MATER MISERICORDIAE UNIVERSITY HOSPITAL · Nov 30, 2022
Trial Information
Current as of January 22, 2025
Completed
Keywords
ClinConnect Summary
Patients undergoing major abdominal and pelvic surgery can have re-admission rates of over 20% in the first 90-days after surgery.
In Ireland the 30-day mortality following emergency abdominal surgery is 6.6%, and 90-day mortality 11.6% (1). Furthermore, 20% of post-operative deaths occur after hospital discharge in those over 80 years of age, of which over 95% occurs during the first six-weeks (2).
Despite this high risk, many patients are discharged home from hospital when medically fit and continuous monitoring discontinues. In hospital, patient monitoring is routine to identify patien...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years of age
- • Scheduled to undergo or recently undergone major intra-cavity abdominal surgery
- • Able to give informed written consent to participate
- Exclusion Criteria:
- • Deemed unfit for surgery
- • Unable or unwilling to comply with remote monitoring for any reason
- • Unable or unwilling to fill in a questionnaire in English
About Mater Misericordiae University Hospital
Mater Misericordiae University Hospital is a leading academic healthcare institution dedicated to advancing patient care through innovative research and clinical trials. Located in Dublin, Ireland, the hospital is renowned for its commitment to improving health outcomes by integrating cutting-edge medical research with clinical practice. As a sponsor of clinical trials, Mater Misericordiae University Hospital collaborates with multidisciplinary teams to facilitate the development of new therapies and interventions, ensuring rigorous adherence to ethical standards and regulatory guidelines. The hospital's focus on patient-centered research underscores its mission to enhance the quality of life for individuals and communities through evidence-based medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dublin 7, , Ireland
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials